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This study aimed to determine the relationship between improvement in lung function and changes in transthoracic 
electrical bioimpedance (TEB) after thoracentesis in patients with pleural effusions. 
Fifteen patients with pleural effusions due to either malignant (n= 8) or cardiac (n=7) diseases were included. 
Pulmonary function was assessed before and after thoracentesis. During thoracentesis the patients were monitored 
with TEB. 
Using linear correlation analysis, the increases for each litre of aspirated thoracic fluid were: forced expiratory 
volume in 1 s (FEV,) 0.26 1; forced vital capacity (FVC) 0.33 1; total lung capacity (TLC) 0.58; and the lung diffusing 
capacity (DLCO); 2.4 ml min - i mmHg - ‘. Baseline impedance increased by 2.3 Ohm l- ’ aspirated thoracic fluid. 
The relative increase in baseline impedance was twice as high for patients with cancer as for patients with heart 
failure (PcO.05). We found only minor changes in systolic blood pressure and mean arterial pressure. 
The improvements in diffusing capacity, airflow, and lung volumes after thoracentesis are correlated to an increase 
in baseline impedance, but changes are dependent on the primary disease. 
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The basis for the clinical observation of relief of dyspnoea 
experienced by patients after thoracentesis has been dis- 
puted. Thoracentesis has been associated with increasing 
lung volume (1) and increases in arterial oxygen tension (2) 
but the reported changes in lung volume have been incon- 
sistent and small. The changes have been characterized as 
being unable to explain the clinically well-known relief of 
dyspnoea in these patients (3), and even lead to the assump- 
tion that it could be a placebo effect (1). Other studies have 
attributed the relief of dyspnoea to changes in mechanical 
variables of respiratory muscle function (4). Changes in 
thoracic fluid volume and cardiac output can be assessed by 
transthoracic electrical bioimpedance (TEB) (5). The 
method has found clinical use in monitoring intensive-care 
patients, especially those with hydrothorax and pulmonary 
oedema. It cannot, however, distinguish between changes in 
intravascular and extravascular fluid volumes (6). The aim 
of this study was to compare changes in pulmonary func- 
tion with changes in TEB related to thoracentesis. Pulmon- 
ary function was assessed before and after thoracentesis. 
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The changes were compared with changes in haemo- 
dynamic variables and the baseline impedance, which 
reflects the amount of fluid present in the thorax. 
Materials and Methods 
PATIENTS 
Sixteen patients, 11 men and five women [median age 67 
years (range 48-77 years)] with pleural effusions due to 
either cardiac (one woman and six men) or malignant 
diseases (four women and five men) participated after 
informed consent. Two patients did not complete both 
measurements of lung diffusing capacity due to fatigue. One 
male patient with lung cancer was excluded from the study 
as he developed pneumothorax during thoracentesis. Four 
of the pleural effusions were sanguinary, the remaining 12 
serous. All pleural effusions were unilateral. All patients 
were in a clinically stable state at the time of examination. 
The local ethics committee for Copenhagen approved the 
study. 
METHODS 
To use an electrical metaphor, the thorax can be viewed 
as a transducer shaped like a truncated cone, with a 
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FIG. 1. Schematic representation of the thorax with 
transmitting (2.5 mA and 70 kHz) and receiving (TEB) 
electrodes. L is the length of the thorax and the distance 
between the inner electrodes. The truncated cone 
represents the theoretical volume of the electrically 
participating tissue. 
steady-state baseline impedance (Z, in Ohm) (7). This 
baseline impedance depends on an intrathoracic volume 
conductor, i.e. fluid or blood. The physical volume of the 
electrically participating tissue is based on the size of the 
patient and can be expressed as a constant (C) dependent 
on the length of the patient’s thorax (L) determined 
from a normogram of height and body weight. C=L3/4.25 
(Fig. 1) (8). 
The impedance changes during the cardiac cycle because 
of the pulsate variations in thoracic aortic blood flow. The 
maximum rate of impedance change (dZ/dt),,, (Ohm s-- ‘) 
within one cardiac cycle is proportional to the peak ascend- 
ing aortic blood flow during systolic upstroke (Fig. 2). This 
change in impedance can be related mathematically to 
stroke volume (SV) by the equation (7): 
SV=C*VET*(dZ/dt),,.JZ,, (equation 1) 
where VET is the ventricular ejection time (Fig. 2). 
TEB was measured with a BoMed (BoMed Medical 
Manufacturing Ltd, Irvine, CA, U.S.A.) impedance cardio- 
graph NCCOM-3 (8). Impedance was measured across the 
thorax between four electrodes placed around the basis 
neck at the level of the lung apex and four electrodes placed 
around the chest at the level of the xiphoid process corre- 
sponding to the level of the lung basis (Fig. 1). A high 
frequency alternating current of 2.5 mA at 70 kHz was sent 
between the two outer sets of electrodes and the impedance 
signal was measured between the inner sets of electrodes. A 
built-in microprocessor provided calculations of VET, 
heart rate (HR), stroke volume (SV), and cardiac output 
(CU) as a mean value of three readings each consisting of 12 
cardiac cycles with acceptable impedance readings (8). 
Thoracentesis was performed with the patient in a fixed 
sitting position. The pleural fluid was aspirated with a 
needle, inserted under local anaesthesia through the eighth 
or ninth intercostal space. Aspiration of thoracic fluid was 
continued until the patients developed symptoms from 
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FIG, 2. Relationship between cardiac cycle as represented 
by ECG, transthoracic impedance (Z), and the first 
differential of Z (dZ/dt). The R wave on the ECG is used 
to trigger the impedance readings. VET is the ventricular 
ejection time. 
pleural irritation such as chest pain or coughing or until no 
more fluid could be withdrawn. Thorax radiographs taken 
shortly after thoracentesis showed no signs of pulmonary 
oedema or pneumothorax in any of the patients except the 
one excluded because of pneumothorax. 
TEB recordings were performed for each 500 ml of 
aspirated pleural exudates as well as before and at 5 and 
10 min after thoracentesis. Stable values of impedance 
readings were obtainable for each step after 1 min. 
Blood pressure was measured along with TEB with an 
arm cuff and a sphygmomanometer. Spirometry and lung 
diffusing capacity assessment were performed using a 
Sensor Medics 2450@ Computerised Pulmonary Function 
Laboratory (CA, U.S.A.). Pulmonary function testing of 
forced expiratory volume in 1 s (FEV,), forced vital capac- 
ity (FVC), total lung capacity (TLC), and lung diffusing 
capacity (DLCO) was performed immediately prior to and 
between 1 and 2 h after thoracentesis according to the 
recommendations of the British Thoracic Society (9). The 
highest of two test results that differed by no more than 3% 
was used as the final test result. TLC and DLCO were 
determined with the single breath technique after inhalation 
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TABLE 1. Changes in TEB variables and blood pressure before, after, and during thoracentesis 
pre 6 500 ml pre 6 1000 ml pre 6 1500ml pre 6 2000 ml 6 10min 
l,, (Ohm) 244 15 25.4*** 22.4 1  24.6*** 19.9 8 22.5** 13.9 4 17.2(*) 2(j.@C+=** 15 
HR (min - ‘) 93 84* 92.5 87.5 89 84.5 84 88.5 91(*) 
dZ/dt,,, (Ohm s-l 10p3) 0.82 0.84 0.77 0.83 0.67 0.82(*) 0.51 0.63 0*93(*) 
SV (ml) 51 54 49 51 49 49.5 39 54 51 
CO (1 min - ‘) 5,5 4.6 4.8 4.7 4.5 4.5 4.3 4.0 4.8 
BPS (mmHg) 150 140 158 140* 158 143(*) 140 132 140*** 
BPD (mmHg) 90 83* 88 80* 90 83(*) 80 80 80 
MAP (mmHg) 108 103* 109 102*** 114 103* 100 98 105*** 
Median values are given for each 500 ml of aspirated fluid and the values before thoracentesis (pre). Statistical method: 
Wilcoxon matched-pairs test. 
n: number of patients; Z,: baseline impedance; HR: heart rate; SV: stroke volume (see equation 1 in the text); CO: 
cardiac output=SV*HR; BPS: systolic blood pressure; BPD: diastolic blood pressure; MAP: mean arterial blood 
pressure=(1/3*(BPS - BPD)+BPD). 
(*)=p<@l; *=p<o.o5; **=p<o.o2; ***=P<@Ol; and ****=P<@OOl. 
TABLE 2. Median values and ranges for lung function variables before and after thoracentesis 
Before thoracentesis After thoracentesis Median change Median change (%) 
FEV, (1 s - ‘) 1.10 (0.52-2.55) 1.40 (0.95-2.65) 0.21 (- 0.07-0.77)** 17.3 (- 6.1-148.1) 
FVC (1) 1.86 (1.03-4.00) 2.05 (1.5tX-4.24) 0.42 (0.02-0.98)** 18.3 (O-673.2) 
vc (1) 2.18 (1.15-4.29) 2.12 (1.474.50) 0.28 (- 0.28-0.82)** 14.2 (- 11.7-60.9) 
RV” (1) 2.38 (1.174.32) 2.56 (1.40-3.73) 0.13 (- 0.59-1.22)* 5.5 (- 13.7-104.3) 
TLC” (1) 4.85 (2.56-7.84) 5.11 (2.67-7.75) 0.26 (- 0.09-1.49)** 5.8 (- 1.1549.2) 
DLCO (ml min - ’ mmHg - ‘) 12.1 (7.3-26.6) 14.1 (10.3-29.9) 1.09 (- 1.60-6.81)* 9.0 ( - 8.0-93.3) 
Volume of aspirated pleural fluid (1) 1.25 (0.13-2.30) 
Statistical method: Wilcoxon matched-pairs test. 
**Difference is significant at the 0.01 level (2-tailed). *Difference is significant at the 0.05 level (2-tailed). 
aYz= 13. 
of a gas mixture containing carbon monoxide and helium 
with the latter as an indicator of the dilution. All patients 
were free from chest pain at the time of the second 
pulmonary function test. 
DATA ANALYSIS 
Linear regression analyses between the volume of aspirated 
pleural effusion, baseline impedance, and lung function 
variables were performed. 
Changes in TEB, mean arterial pressure, blood pressure, 
and lung function variables before and after thoracentesis 
were compared using the Wilcoxon non-parametric test for 
paired data. The comparison of changes in Z, between 
groups of patients was made using the Mann-Whitney 
U-test. 
Results 
The median amount of aspirated thoracic fluid was 1250 ml 
(range 325-2300 ml). All patients experienced a relief of 
dyspnoea after thoracentesis. Both relief of dyspnoea and 
changes in lung function variables after thoracentesis were 
independent of underlying ventilatory defects. 
Table 1 shows changes in central haemodynamic vari- 
ables and Z, for each 500 ml amount of aspirated thoracic 
fluid as well as values obtained 10 min after thoracentesis. 
Baseline impedance increased significantly with each 500 ml 
of aspirated thoracic fluid. There were no changes in HR 
apart from a temporary decrease after aspiration of the first 
500 ml of thoracic fluid. The patients had slight but signifi- 
cantly lower systolic and mean arterial blood pressure 
10 min after thoracentesis, while diastolic blood pressure 
showed a trend towards a decrease. 
Table 2 shows the results of the lung function test before 
and after thoracentesis. The patients had a significant 
increase of 5.5-18% from baseline values in the reported 
lung function variables. 
Figure 3 illustrates the physiological effect on or thera- 
peutic gain of lung function variables and changes in Z, 
when aspiring pleural effusions. From a visual evaluation of 
Fig. 3, it appears that there is a larger relative beneficial 
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FIG. 3. Effect of aspirated pleural volume on changes in 
baseline impedance (Z,), forced expiratory volume in 1 s 
(FEV,), forced vital capacity (FVC), total lung capacity 
(TLC), and lung diffusing capacity (DLCO). Slopes and 
significance levels are derived from a linear regression 
model. 0: Heart patients, 0: cancer patients. 
effect on TLC and DLCO in patients with pleural effusions 
over 1 1 compared to patients with smaller pleural effusions. 
FEV,, FVC, and Z,, however, seem to be dependent on the 
aspirated volume of pleural fluid in a more linear fashion. 
Correlation coefficients between the aspirated volume of 
thoracic fluid, changes in lung function variables and 
changes in Z, are shown in Table 3. 
The transfer coefficient (DLVa) did not increase as five 
out of eight of the patients with malignant diseases had 
declining values of DLVa after thoracentesis (three of these 
five patients had primary lung cancer). 
There was no correlation between the haemodynamic 
variables and the aspirated amount of thoracic fluid vol- 
ume. Even though (dZ/dt),,, showed a tendency towards 
an increase after thoracentesis, no correlation was found 
between (dZ/dt),,, and Z, or the amount of aspirated 
thoracic fluid. 
Equal amounts of thoracic fluid were aspirated in 
patients with cancer [median 1.29 1 (range 620-2000ml)] 
and heart disease [median 1.25 1 (325-2300 ml)]. However, 
cancer patients had almost twice the increase in baseline 
impedance [median 2.8 Ohm (range 24-4.5 Ohm)] as 
patients with heart disease [median 1.3 Ohm (range 
0.1-6.7 Ohm)]. This was seen most consistently for the 
percentage changes in Z,. Cancer patients had a 16% 
increase in Z, per litre of aspirated fluid in contrast to 7% in 
heart patients (WO.05). There were no significant differ- 
ences in changes in Z. when patients were divided into 
groups according to gender, body weight, height, obese 
versus lean, or type of respiratory disease (restrictive/ 
obstructive). 
There was no change in baseline impedance between 
measurements performed at the end of thoracentesis and 
those performed 10 min after the procedure. 
Discussion 
Thoracentesis was closely correlated to improvements in 
lung function and an increase in baseline impedance. In 
general, studies of the physiological effect of aspirating 
pleural effusions have been small with inconsistent results. 
It has even been suggested that the relief of dyspnoea could 
be a placebo effect (1). This led Estenne et al. to examine the 
mechanical variables of lung function (4). They concluded 
that the relief of dyspnoea following thoracentesis primarily 
is due to a reduction in the volume of the thoracic cage, 
allowing the inspiratory muscles to operate at a more 
advantageous part of their length-tension curve. On the 
other hand Mahler et al. (10) have found the relief of 
dyspnoea to be well correlated with changes in spirometric 
values. 
The present data clearly demonstrates that thoracentesis 
is related to an increase in respiratory flow, volume and 
diffusing capacity. Our data provide a basis for estimations 
of improvement in lung function variables from the amount 
of aspirated thoracic fluid. The most marked improvement 
in lung function was found in FEV, and DLCO. These 
findings support both the conclusion of Estenne et al., as 
mentioned above and Perpina et al. (2)), who found major 
improvements in gas exchange after thoracentesis. How- 
ever, thoracentesis appears to be of greatest benefit to 
DLCO and TLC when the aspirated fluid volume exceeds 
1 1. Light et al. have found a similar threshold value for VC 
at 800 ml of removed fluid, regarding the correlation 
between changes in VC and pleural pressure (11). These 
findings indicate that the relief of dyspnoea when aspirating 
small fluid volumes (i.e. less than 1 1) is mainly due to a 
reduction in the volume of the thoracic cage, facilitating an 
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TABLE 3. Pearson correlation matrix between aspirated volume of pleural fluid (volume) and changes 
in lung function variables and baseline impedance (Z,) 
Volume dFEV, dFVC dVC dRV” dTLC” dDrC0” 
dFEV, 
dFVC 
dVC 
dRV, 
dTLC” 
dDrC0” 
dzo 
0.68** 
0.70** - 
- 0.51* 
- - 
0.75** - 0.84** 0.66* 
0.61* 0.47(*) 0.52(*) - 0.78** 
0.85** 0.68** 0.50(*) 0.68* 
**, Correlation is significant at the 0.01 level (2-tailed); *, correlation is significant at the 0.05 level 
(2-tailed); (*), trend towards correlation at 0.05 <P<O.lO; - , no correlation. 
“n=13. 
increase in FVC and FEV, due to improved function of the 
respiratory musculature. Only larger volumes of aspirated 
fluid result in increases in TLC. 
Other authors have described a linear correlation 
between changes in Z, and changes in pleural effusion or 
central blood volume in both humans (12) and in dogs (13). 
An even closer correlation between changes in Z, and 
changes in lung function variables may have been demon- 
strated had the impedance readings been extended to the 
time of lung function measurement (14). Although there is 
a significant correlation between changes in baseline imped- 
ance in Ohms and changes in the amount of thoracic fluid, 
it is not possible to predict the exact amount of thoracic 
fluid from baseline impedance readings (15). However, 
Saunders et al. (6) have found transthoracic electrical 
bioimpedance assessment useful as a non-invasive method 
of monitoring changes in the amount of thoracic fluid in 
intensive-care patients. Also, Campbell et al. (16) have 
reported similar findings using a tomographic technique 
based upon changes in thoracic impedance. Our data 
support these findings and provide a direct estimate of the 
amount of fluid accumulated with a given change in 
baseline impedance. However, the primary disease has a 
significant impact on the relative changes in Z, as a 
function of the aspirated volume of thoracic fluid. This 
can be interpreted as a result of patients with heart 
failure having a higher overall fluid content in the thorax 
than patients with malignant diseases, because of an 
increased filling of the vascular bed of the lungs due to a 
backward failure (17). Thus, the smaller relative changes in 
Z, per amount of aspirated fluid volume in patients with 
heart failure could be explained by the lesser relative 
contribution of the aspirated fluid volume to the total 
impedance. 
As baseline impedance (Z,) had changed during thora- 
centesis, an unchanged SV under these conditions in fact 
reflects an increase in (dZ/dt),,, (see equation 1). In spite of 
a tendency towards an increase in (dzldt),,, after thora- 
centesis, no correlation was found between (dZ/dt),,, and 
Z, or the aspirated amount of thoracic fluid. Thus, our data 
are not conclusive regarding statements of changes in 
cardiac output as a function of the aspirated thoracic 
fluid volume. The decrease in systolic and mean arterial 
pressures seen 10 min after thoracentesis may be due to 
relief of distress related to the procedure, rather than its 
effect. The decline in mean arterial and systolic blood 
pressure and the trend towards a lower heart rate after 
aspiration of the first 500 ml of fluid may be seen as a 
parallel to the vagal response when perforating the perito- 
neum and/or relief from thoracic fluid compressing the 
heart. 
In conclusion, we have found a close correlation between 
the drying effect of thoracentesis and changes in both 
baseline impedance of the thorax and subsequent 
improvements in pulmonary airflow, lung volume and 
lung diffusing capacity. The present study provides a 
basis for estimating the magnitude of the physiological 
effect of a given amount of aspirated fluid volume. How- 
ever, the changes in Z, appear to be dependent on the 
disease of the patient, reflecting the overall fluid content of 
the thorax. 
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